|
| Analyst
Scorecard | | Analyst: | Napodano, Jason | EPS
Est. Accuracy: | Not Avl.
| | Broker: | Zacks Investment Research | Recommendation
Performance: | Not Avl.
|
|
What is this?
This scorecard presents a summary of StarMine ratings
for this analyst.
Ratings are displayed when analysts score highly based
on the accuracy of
their earnings estimates or the returns of their stock
recommendations. Stocks
which appear on this scorecard are limited to those
covered by the analyst for
a significant period of time. Learn
More
|
| |
EPS Estimate Accuracy
| | |
Symbol
|
Company Name
|
EPS Est. Accuracy
|
No. Analysts
| | | |
CYTX
|
Cytori Therapeutics Inc
|
|
7
| | | | |
NGSX
|
Neurogesx Inc
|
|
6
| | | |
| Other Stocks Covered
| |
Acadia Pharmaceuticals Inc (ACAD), Acorda Therapeutics Inc (ACOR), Acusphere Incorporated (ACUS), Anesiva Inc (ANSV), Arena Pharmaceuticals Inc (ARNA), Neurocrine Biosciences Inc (NBIX), Pozen Inc (POZN), Somaxon Pharmaceuticals Inc (SOMX), Viropharma Inc (VPHM), Xoma Ltd (XOMA)
|
| | |
|
|
|
